Journal
CLINICAL BIOCHEMISTRY
Volume 44, Issue 2-3, Pages 216-220Publisher
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.clinbiochem.2010.11.002
Keywords
Malignant effusions; Cell-free miRNAs; miR-24; miR-30d; Diagnosis
Categories
Funding
- National Natural Science Foundation of Jiangsu [SBK20082388]
- Science and Technology Development Plan of Nanjing [200801078]
Ask authors/readers for more resources
Objectives: The study was trying to figure out the possible role of cell-free miR-24 and miR-30d as diagnostic biomarkers for malignant effusions. Methods: A total of 110 effusion samples (28 benign and 82 malignant) were collected and cell-free total RNA was extracted. Quantitative RT-PCR was carried out to measure the expression levels of miR-24 and miR-30d, with an exogenous supplemented plant miRNA, ath-miR156a as the reference RNA. Results: Malignant pleural effusions had higher expression levels of cell-free miR-24 and miR-30d than benign effusions. In the ascites group, only miR-30d was found to be significantly up-regulated in the supernatant of effusions. Combination of cell-free miR-24 and miR-30d could discriminate malignant ascites from benign with improved potency comparing to single miR-30d. Conclusions: Cell-free miR-30d and miR-24 are potential diagnostic biomarkers for malignant and benign effusions. (C) 2010 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available